Sponsors

RECENT NEWS

​AMR-related infections caused over 3 million child deaths in 2022

A landmark study presented at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

£9 million investment fuels groundbreaking bioscience research

UK Research and Innovation’s Biotechnology and Biological Sciences Research Council (BBSRC) has announced £9 million in funding for a variety of bioscience projects, with its prestigious 2024 Fellowships scheme supporting 19 future science leaders

Roche announces US investment in diagnostics

Roche has announced an investment of US $50 billion into the United States of America in the next five years across its pharmaceutical and diagnostics divisions.

ARUP launches pTau 217 blood test to detect Alzheimer's

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.

Partnership to develop AI models for MS

Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, has announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organisation dedicated to accelerating research and improving outcomes for people with multiple sclerosis (MS).

$10 million invested in AI disease detection at University of Pittsburgh

Leidos is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).

Breakthrough study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women

A pioneering study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6’s diagnostic performance in a real-world cohort across all three populations.

3D pathology results in more precise breast cancer treatment

The preliminary results of a research collaboration between JelloX Biotech - a Taiwan-based startup at the forefront of cancer pathology – and the National Taiwan University Hospital (NTUH) on breast cancer patients shows that 3D pathology technology leads to more precise treatment for breast cancer patients.

RDi completes strategic acquisition of Inicio Health

LDC-backed RDi, a leader in data driven, automated self-sampling kits for healthcare, is pleased to announce the successful acquisition of Inicio Health, a pioneering force in healthcare interoperability, automation and AI solutions.

At-home saliva test better than blood test at detecting prostate cancer

A simple at-home saliva test may be more accurate at detecting prostate cancer than the current prostate-specific antigen (PSA) blood test, new National Institute for Health and Care Research (NIHR)-funded research suggests.

NHS expands trial of skin cancer vaccine

Patients with advanced skin cancer in England are set to be fast-tracked into trials of a new cancer vaccine, following the expansion of a world-leading NHS programme.

Sphere Bio expands Asia Pacific distribution network

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, has announced a significant expansion of its Asia Pacific distributor network.

Antibiotic resistance among key bacterial species plateaus over time

Antibiotic resistance tends to stabilise over time, according to a recent study, which also showed use of antibiotics was weakly associated with resistance, indicating additional factors may be at play.

Source BioScience acquires Cambridge Clinical Laboratories

Source BioScience has announced the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services.

Clean Cells acquires Karyologic to accelerate expansion in US biologics market​

Clean Cells, part of the Clean Biologics group, a leading biopharmaceutical quality control services provider specialising in biologics GMP testing, has announced the strategic acquisition of Karyologic Inc, a specialised karyotyping services company based in Durham, North Carolina, USA.

New polypropylene tips enable parallel pipetting of 1536 channels

Analytik Jena is expanding its liquid handling portfolio with a new 1536-tip tray for the CyBio Well vario. In combination with the appropriate pipetting head, this consumable enables parallel pipetting in 1,536 channels.

WHO confirms MHRA role ensuring safe biological medicines

The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products Regulatory Agency (MHRA) Science and Research group as one of its Collaborating Centres for the Standardisation and Evaluation of Biologicals for the next four years.

Human IgG Kappa and Viability Assay Kit for efficient single-cell selection launched

Sphere Bio has launched the Cyto-Cellect Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the company’s new Cyto-Mine Chroma platform.

A step forward in developing new treatment for E. coli infections

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), which is associated with severe food poisoning.

Lab Innovations claims top event award

Lab Innovations, the UK’s meeting place for laboratory professionals across the scientific spectrum, won the Award for Best Trade Show under 5000 square metres at the Exhibition News award ceremony on 31 March 2025.

Latest Issues

GenQA at ESCV 2025

Thessaloniki Concert Hall
17 September, 2025

IBMS Congress

The International Convention Centre (ICC), Birmingham
22-25 September, 2025

Diagnostics North East Conference 2025

The Catalyst, Newcastle
3 October